Modified crosslinked stroma-free tetrameric hemoglobin

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 4529719
SERIAL NO

06497454

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Stroma-free deoxy mammalian tetrameric hemoglobin is crosslinked with certain bis diaspirin esters and modified with pyridoxyl-5'-phosphate followed by reduction to produce bis-diamide covalently crosslinked, pyridoxal-5'-phosphate covalently modified tetrameric hemoglobin wherein the crosslinking and modifying bonds occur in the beta cleft. The modified crosslinked stroma-free tetrameric hemoglobin of this invention is a disease-free, oxygen transporting discrete molecular species, free from cell surface antigens, having use as a substitute for transfusion of red blood cells. This modified crosslinked stroma-free hemoglobin is a stable oxygen carrying protein capable of oxygen delivery to perfused tissue and advantageously remaining in the intravascular space.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
TYE ROSS WSAUSALITO CA 94965

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Tye, Ross W 937 B Rosenstock Rd., Sausalito, CA 94965 2 160

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation